Parathyroplex Liquid
NDC Package 43857-0205-1
Package Information
Parathyroplex (parathyroid gland (bovine), baryta carbonica, calcarea carbonica, calcarea fluorica, calcarea phosphorica, cuprum metallicum, magnesia phosphorica, manganum metallicum, rhus tox, silicea) liquids is for temporary relief of weakness of extremities, cramps in the calves, swelling of joints, arthritic tendencies, and sensitiveness to cold, worse in winter. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc., this product is identified by NDC 43857-0205.
Identification & Billing
Clinical Specifications
- BARIUM CARBONATE 12 [hp_X]/mL
- BOS TAURUS PARATHYROID GLAND 6 [hp_X]/mL
- CALCIUM FLUORIDE 12 [hp_X]/mL
- COPPER 12 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 12 [hp_X]/mL
- MANGANESE 12 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/mL
- SILICON DIOXIDE 12 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 12 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE 12 [hp_X]/mL
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 43857 - Bioactive Nutritional, Inc.
- 43857-0205 - Parathyroplex
- 43857-0205-1 - 30 mL in 1 BOTTLE, DROPPER
- 43857-0205 - Parathyroplex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43857-0205-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Parathyroplex, a human over the counter drug labeled by Bioactive Nutritional, Inc.. This liquid is formulated for oral use and contains barium carbonate; bos taurus parathyroid gland; calcium fluoride; copper; magnesium phosphate, dibasic trihydrate; manganese; oyster shell calcium carbonate, crude; silicon dioxide; toxicodendron pubescens leaf; tribasic calcium phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc. on August 21, 2013. The current certification is valid through December 31, 2026.
How is this Bioactive Nutritional, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857020501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.